Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Gerhard, Fierlbeck"'
Autor:
Anja Ulmer, Klaus Dietz, Isabelle Hodak, Bernhard Polzer, Sebastian Scheitler, Murat Yildiz, Zbigniew Czyz, Petra Lehnert, Tanja Fehm, Christian Hafner, Stefan Schanz, Martin Röcken, Claus Garbe, Helmut Breuninger, Gerhard Fierlbeck, Christoph A Klein
Publikováno v:
PLoS Medicine, Vol 11, Iss 2, p e1001604 (2014)
BACKGROUND: Sentinel lymph node spread is a crucial factor in melanoma outcome. We aimed to define the impact of minimal cancer spread and of increasing numbers of disseminated cancer cells on melanoma-specific survival. METHODS AND FINDINGS: We anal
Externí odkaz:
https://doaj.org/article/5336b288bcc64d9dba97cf1db6751fd4
Autor:
Ulf Müller-Ladner, Tracy M. Frech, Murray Baron, Jeffrey Siegel, Daniel E. Furst, Angelika Jahreis, Yannick Allanore, Laura Burke, Gerhard Fierlbeck, Christopher P. Denton, Dinesh Khanna, Janet E. Pope, Helen Spotswood, Gabriela Riemekasten, Virginia D. Steen, Lorinda Chung, Marina E Anderson, Santhanam Lakshminarayanan, Celia J. F. Lin, Jacob M van Laar
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesAssess the efficacy and safety of tocilizumab in patients with systemic sclerosis (SSc) in a phase II study.MethodsPatients with SSc were treated for 48 weeks in an open-label extension phase of the faSScinate study with weekly 162 mg subcu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af4ac95db0539a2545e641b7e077e35
http://europepmc.org/articles/PMC5867414
http://europepmc.org/articles/PMC5867414
Autor:
Michael Hertl, Rüdiger Eming, Giampiero Girolomoni, Detlef Zillikens, Alexander Enk, Beatrix Volc-Platzer, Georg Stingl, Sarolta Kárpáti, Stephen Jolles, Kerstin Steinbrink, Gerhard Fierlbeck, Lars E. French, Eva Hadaschik
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 15:228-241
Background The treatment of severe dermatological autoimmune diseases and toxic epidermal necrolysis (TEN) with high-dose intravenous immunoglobulin (IVIg) is a well-established procedure in dermatology. As treatment with IVIg is usually considered f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78a4468d01688c7858739ea9261f764
https://doi.org/10.1111/ddg.13013
https://doi.org/10.1111/ddg.13013
Autor:
Pia, Moinzadeh, Gabriela, Riemekasten, Elise, Siegert, Gerhard, Fierlbeck, Joerg, Henes, Norbert, Blank, Inga, Melchers, Ulf, Mueller-Ladner, Marc, Frerix, Alexander, Kreuter, Christian, Tigges, Nina, Lahner, Laura, Susok, Claudia, Guenther, Gabriele, Zeidler, Christiane, Pfeiffer, Margitta, Worm, Sigrid, Karrer, Elisabeth, Aberer, Agnes, Bretterklieber, Ekkehard, Genth, Jan C, Simon, Joerg H W, Distler, Ruediger, Hein, Matthias, Schneider, Cornelia S, Seitz, Claudia, Herink, Kerstin, Steinbrink, Miklos, Sárdy, Rita, Varga, Hartwig, Mensing, Christian, Mensing, Percy, Lehmann, Gunther, Neeck, Christoph, Fiehn, Manfred, Weber, Matthias, Goebeler, Harald, Burkhardt, Michael, Buslau, Keihan, Ahmadi-Simab, Andrea, Himsel, Aaron, Juche, Ina, Koetter, Annegret, Kuhn, Michael, Sticherling, Martin, Hellmich, Kathrin, Kuhr, Thomas, Krieg, Jan, Ehrchen, Cord, Sunderkoetter, Nicolas, Hunzelmann, Michael P, Schoen
Publikováno v:
The Journal of Rheumatology. 43:66-74
Objective.Vasculopathy is a key factor in the pathophysiology of systemic sclerosis (SSc) and the main cause for Raynaud phenomenon (RP), digital ulcers (DU), and/or pulmonary arterial hypertension (PAH). It is so far unknown how patients with SSc ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a60786e82605436178cc0cccf20c3a0
https://doi.org/10.3899/jrheum.150382
https://doi.org/10.3899/jrheum.150382
Autor:
Martin Röcken, Claus Garbe, Gerhard Fierlbeck, Klaus Dietz, Anja Ulmer, Claudia Schulz, Hans-Martin Häfner, Christoph Klein, Florian Weber, Melanie Werner-Klein, Helmut Breuninger, Philipp Renner
Publikováno v:
European journal of cancer (Oxford, England : 1990). 91
Introduction Complete lymph node dissection (CLND) after a positive sentinel node (SN) biopsy provides important prognostic information in melanoma patients but has been questioned for therapeutic use recently. We explored whether quantification of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65f86aa99512bd9e34eb606e2bd0978
https://pubmed.ncbi.nlm.nih.gov/29316475
https://pubmed.ncbi.nlm.nih.gov/29316475
Autor:
Tracy M. Frech, Lorinda Chung, Janet E. Pope, Jeffrey Siegel, Helen Spotswood, Laura Burke, Ulf Müller-Ladner, Dinesh Khanna, Santhanam Lakshminarayanan, Gabriela Riemekasten, Jacob M van Laar, Virginia D. Steen, Christopher P. Denton, Yannick Allanore, Gerhard Fierlbeck, Daniel E. Furst, Murray Baron, Michael B. Arnold, Angelika Jahreis, Marina E Anderson
Publikováno v:
Rheumatology (Oxford, England). 57(1)
OBJECTIVES: Patient acceptable symptom state (PASS) as an absolute state of well-being has shown promise as an outcome measure in many rheumatologic conditions. We aimed to assess whether PASS may be effective in active diffuse cutaneous SSc differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7cb726ec1b5a524284d9ce5a0dd6ea3
https://pubmed.ncbi.nlm.nih.gov/29077900
https://pubmed.ncbi.nlm.nih.gov/29077900
Autor:
Elisabeth Aberer, Pia Moinzadeh, Ekkehard Genth, G. Zeidler, Hartwig Mensing, Thomas Krieg, and all participating Dnss centers, Hanns-Martin Lorenz, Alexander Kreuter, Kathrin Kuhr, Gottfried Wozel, Keihan Ahmadi-Simab, Gerhard Fierlbeck, C. Guenther, Ulf Mueller-Ladner, I. Herrgott, Peter Vaith, Miklós Sárdy, Margitta Worm, Gabriela Riemekasten, I. Koetter, Inga Melchers, Ingo H. Tarner, Christiane Pfeiffer, J. H. W. Distler, Florian M P Meier, Norbert Blank, Marc Schmalzing, R. Hein, Joerg Henes, C. Sunderkoetter, Lena Herich, Nicolas Hunzelmann, Laura Susok
Publikováno v:
Annals of the Rheumatic Diseases
Background: Systemic sclerosis (SSc)-overlap syndromes are a very heterogeneous and remarkable subgroup of SSc-patients, who present at least two connective tissue diseases (CTD) at the same time, usually with a specific autoantibody status. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a93552758c07108e3d6b751c581472
https://doi.org/10.1136/annrheumdis-2013-204487
https://doi.org/10.1136/annrheumdis-2013-204487
Autor:
Michael Eisfelder, Daniel Spira, Bjoern Knaudt, Annette Adamczyk, Gerhard Fierlbeck, Eva Ziupa, Marius Horger, I. Koetter, Joerg Henes, Lothar Kanz, Juergen Lux, Felix Jacobs, Stefan Schanz
Publikováno v:
Rheumatology International. 34:227-234
The exact prevalence of psoriatic arthritis (PsA) among patients with psoriasis is still not conclusive. Data in the literature vary between 5.8 and 30 %. Objective of this study was to gain more information on the prevalence of PsA among patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a86c03241c0645cca9f679868d39cf35
https://doi.org/10.1007/s00296-013-2876-z
https://doi.org/10.1007/s00296-013-2876-z
Autor:
Wolfram Hoetzenecker, Emmanuella Guenova, Vanyo Mitev, Stefan Schanz, Anja Ulmer, Gerhard Fierlbeck
Publikováno v:
European Journal of Dermatology. 23:653-657
Pyoderma gangrenosum (PG) is a severe ulcerative skin disease. Despite systemic immunosuppressive therapy, PG ulcers often progress and can develop into life-threatening conditions. In this case series, we treated 6 patients suffering from recalcitra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3a38f88b10265c9b09901dee8b47e4
https://doi.org/10.1684/ejd.2013.2147
https://doi.org/10.1684/ejd.2013.2147
Autor:
Marius Horger, Marc Schmalzing, I. Koetter, Joerg Henes, Gerhard Fierlbeck, Christopher Amberger, Lothar Kanz
Publikováno v:
Clinical Rheumatology. 32:673-678
The purpose of this study was to assess the impact of enteric-coated mycophenolate sodium (EC-MPS) on skin and pulmonary manifestations of patients with progressive systemic sclerosis (Ssc). A prospective, open-label single-centre trial with EC-MPS 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f0ba3497076e159728e4d7d14be3c5
https://doi.org/10.1007/s10067-012-2155-5
https://doi.org/10.1007/s10067-012-2155-5